CVS

Briefing on the Fundamentals of CVS Health (CVS)

CVS Health moved -0.41% this afternoon session, trading between a high of $77.62 and a low of $75.9 per share. Yesterday the stock finished at $77.0 per share, compared to an average analyst target price of $113.52.

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The large-cap healthcare plans company is based in the United States, and over the last twelve months it has returned a dividend yield of 3.14%. CVS Health has trailing twelve months earnings per share (EPS) of 3.121, which at today's prices amounts to a price to earnings (P/E) ratio of 24.6.

Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 1.359. Usually a PEG ratio between zero and one indicates a potentially undervalued company.

Here's an overview of the company's gross margins in recent years:

Date Reported Revenue (k) Cost of Revenue (k) Gross Margin YoY Growth
2022-12-31 $322,467,000 $345,066,000 -7.01% -26.76%
2021-12-31 $292,111,000 $308,255,000 -5.53% -45.91%
2020-12-31 $268,706,000 $278,888,000 -3.79% 9.55%
2019-12-31 $256,776,000 $267,544,000 -4.19% -155.79%
2018-12-31 $194,579,000 $179,963,000 7.51% n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

ON FOCUS